Radiomic and clinical data integration using machine learning predict the efficacy of anti-PD-1 antibodies-based combinational treatment in advanced breast cancer: a multicentered study.
Jianli ZhaoZhixian SunYunfang YuZhongyu YuanYing LinYujie TanXiaohui DuanHerui YaoYing WangJieqiong LiuPublished in: Journal for immunotherapy of cancer (2023)
This radiomics model provided an innovative and accurate way that could stratify patients with ABC who may benefit more from ICIs-based therapies.